SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1631Not that much to translate; Amgen apparently hopes to test patients for KRAS muttuck-3/10/2008
1630can someone translate? too bad they can't find a marker for those who would JGoren-3/5/2008
1629KRAS Biomarker Analysis from Pivotal Vectibix(TM) Trial Published Tuesday March mopgcw-3/4/2008
1628Forbes: Amgen Ailing Along With Anemia Drugs Carl Gutierrez, 02.27.08, 10:50 AM mopgcw-2/27/2008
1627Study Finds Death Risk From Anemia Drugs [NYT] By ANDREW POLLACK Published: FebDoc Bones-2/27/2008
1626<b>CHMP has recommended approval of four biosimilar versions of Neupogen&lidos-2/21/2008
1625Up a whopping $.47!!! Way to go! Just $13 more and the options received by retsteve kammerer-2/13/2008
1624Are you nuts? Most of us long-term holders sell covered calls to bring in some cJGoren-2/11/2008
1623Hey guys, We need someone to get Amgen up to 70, or better yet, 80 for one day tsteve kammerer-2/11/2008
162291 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS Xpiderman-2/3/2008
1621citi: Amgen Inc (AMGN) OK '08 Guidance & Good Dmab Data: Are The Tides Cmopgcw-2/2/2008
1620agree. If ultimately successful, it could also be starting point for further resJGoren-1/11/2008
1619Peter suggested Amgen might trial the idea. No safety hurdle to speak of, as thtuck-1/11/2008
1618thanks. interesting. since it's not a blind, scientific study, it shouldnJGoren-1/10/2008
1617bloomberg.comDewDiligence_on_SI-1/10/2008
1616I must be blind; still can't find an article about alzheimersJGoren-1/10/2008
1615J No...i didn't explain it properly. If you go back to my link and scroll dSirWalterRalegh-1/10/2008
1614I assume you meant this article: thisislondon.co.ukJGoren-1/10/2008
1613Posted on DRUDGE today... thisislondon.co.ukSirWalterRalegh-1/10/2008
1612Amgen's Outlook Brightens By MARILYN CHASE January 9, 2008; [WSJ] Page B10 Doc Bones-1/9/2008
1611>>FDA Reviewing Risks of Anemia Drugs Thursday January 3, 1:32 pm ET By Mtuck-1/3/2008
1610Amgen's science doesn't guarantee profits The biotech has a promising trJGoren-12/18/2007
1609Amgn Shares Reach New Low on Drug Data salient parts: "But, Wall Street qJGoren-12/17/2007
1608Amgen (AMGN) drug trials cause worry Posted Dec 17th 2007 12:36PM by Brent ArcheJGoren-12/17/2007
1607AMGN reported positive ph.III data for denosumab in the treatment of non-metastaidos-12/17/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News